Correlation Between Rani Therapeutics and Vincerx Pharma
Can any of the company-specific risk be diversified away by investing in both Rani Therapeutics and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rani Therapeutics and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rani Therapeutics Holdings and Vincerx Pharma, you can compare the effects of market volatilities on Rani Therapeutics and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rani Therapeutics with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rani Therapeutics and Vincerx Pharma.
Diversification Opportunities for Rani Therapeutics and Vincerx Pharma
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Rani and Vincerx is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Rani Therapeutics Holdings and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Rani Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rani Therapeutics Holdings are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Rani Therapeutics i.e., Rani Therapeutics and Vincerx Pharma go up and down completely randomly.
Pair Corralation between Rani Therapeutics and Vincerx Pharma
Given the investment horizon of 90 days Rani Therapeutics Holdings is expected to generate 0.23 times more return on investment than Vincerx Pharma. However, Rani Therapeutics Holdings is 4.39 times less risky than Vincerx Pharma. It trades about 0.03 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.02 per unit of risk. If you would invest 130.00 in Rani Therapeutics Holdings on October 20, 2024 and sell it today you would earn a total of 1.00 from holding Rani Therapeutics Holdings or generate 0.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rani Therapeutics Holdings vs. Vincerx Pharma
Performance |
| Timeline |
| Rani Therapeutics |
| Vincerx Pharma |
Rani Therapeutics and Vincerx Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rani Therapeutics and Vincerx Pharma
The main advantage of trading using opposite Rani Therapeutics and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rani Therapeutics position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
| Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |